Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIND Therapeutics Inc (NASDAQ:BIND)

0.398
Delayed Data
As of 4:00pm ET
 +0.0069 / +1.76%
Today’s Change
0.35
Today|||52-Week Range
5.98
-82.62%
Year-to-Date
7 Biotech Stocks that are Buys Right Now
Jun 17 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.39
Today’s open0.43
Day’s range0.38 - 0.43
Volume227,833
Average volume (3 months)418,125
Market cap$8.2M
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+8.12%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+47.72%
P/E ratioNM
Price/Sales3.01
Price/Book0.48

Competitors

 Today’s
change
Today’s
% change
BNTCBenitec Biopharma Lt...0.000.00%
STEMStemCells Inc+0.00+1.02%
IGCIndia Globalization ...+0.01+1.73%
CBMXCombiMatrix Corp+0.12+4.20%
Data as of 3:59pm ET, 07/01/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$15.4M
Annual profit (last year)-$36.6M
Net profit margin-237.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, CAO &
Director
Andrew J. Hirsch
Vice President-Discovery &
Research
Stephen Zale
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs